Former ByteDance AI scientist touts drug-discovery model that tops world leaders

AI Summary

Geodesic Intelligence, founded by former ByteDance scientist Quanquan Gu, says its NovaAtom-Lite model outperformed leading systems on several drug-discovery benchmark tasks. The model predicts biomolecular structures and interactions, adding to competition in AI-enabled life sciences.

A former ByteDance artificial intelligence scientist’s new venture has released a life sciences AI model that the firm claims outperforms state-of-the-art systems, intensifying the increasingly crowded competition in AI-driven drug discovery. Geodesic Intelligence’s NovaAtom-Lite, an AI model designed to predict the structures and interactions of biomolecules, topped a third-party benchmark in several drug discovery tasks, founder Quanquan Gu said on social media on Wednesday. On the FoldBench...